INTENSITY THERAPEUTICS, INC. ($INTS) Insider Transactions

Last updated: 2026-03-30 23:09 UTC | Total transactions: 24

In the last 12 months, insiders at INTENSITY THERAPEUTICS, INC. ($INTS) filed 24 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.

INTENSITY THERAPEUTICS, INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).

Most Active Insiders

View all SEC Filings for INTENSITY THERAPEUTICS, INC. (INTS).

Set Up your own filters →

Recent Insider Transactions

Transaction Date Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 26, 2026 BENDER LEWIS H President and CEO A Common Stock, $0.0001 Par Value 37749 $6.11 118,549.0000 60,064,965 46.72% 0.06%
Dec. 31, 2025 Talamo Joseph Chief Financial Officer A Common Stock, $0.0001 Par Value 14482 $0.26 28,661.0000 60,064,965 102.14% 0.02%
Dec. 31, 2025 Wesolowski John M Principal Accounting Officer A Common Stock, $0.0001 Par Value 8918 $0.26 85,354.0000 60,064,965 11.67% 0.01%
June 30, 2025 Wesolowski John M Principal Accounting Officer A Common Stock, $0.0001 Par Value 69745 $0.26 76,436.0000 15,180,945 1042.37% 0.46%
June 30, 2025 Talamo Joseph Chief Financial Officer A Common Stock, $0.0001 Par Value 14179 $0.26 14,179.0000 15,180,945 9999.99% 0.09%
May 2, 2025 GOLDBERG MARK A Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 15,180,945 9999.99% 0.33%
May 2, 2025 Leahy Emer Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 15,180,945 9999.99% 0.33%
May 2, 2025 Wesolowski John M Principal Accounting Officer A Stock Option (right to buy Common Stock) 100000 $0.00 100,000.0000 15,180,945 9999.99% 0.66%
May 2, 2025 BENDER LEWIS H President and CEO A Stock Option (right to buy Common Stock) 700000 $0.00 700,000.0000 15,180,945 9999.99% 4.61%
May 2, 2025 Talamo Joseph Chief Financial Officer A Stock Option (right to buy Common Stock) 300000 $0.00 300,000.0000 15,180,945 9999.99% 1.98%
May 2, 2025 Donovan Daniel Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 15,180,945 9999.99% 0.33%
May 2, 2025 DUBIN THOMAS I H Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 15,180,945 9999.99% 0.33%
May 2, 2025 Wesolowski John M Principal Accounting Officer A Stock Option (right to buy Common Stock) 100000 $0.00 100,000.0000 15,180,945 9999.99% 0.66%
Oct. 21, 2024 Wesolowski John M Principal Accounting Officer A Stock Option (right to buy Common Stock) 70028 $0.00 70,028.0000 0 9999.99% 0.00%
Oct. 21, 2024 Talamo Joseph Chief Financial Officer A Stock Option (right to buy Common Stock) 427379 $0.00 427,379.0000 0 9999.99% 0.00%
June 5, 2024 Wesolowski John M Principal Accounting Officer M Stock Option (right to buy Common Stock) 1000 $0.00 14,000.0000 0 6.67% 0.00%
June 5, 2024 Wesolowski John M Principal Accounting Officer M Common Stock, $0.0001 Par Value 1000 $4.00 6,691.0000 0 17.57% 0.00%
May 14, 2024 DUBIN THOMAS I H Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 0 9999.99% 0.00%
March 6, 2024 Donovan Daniel Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 0 9999.99% 0.00%
March 6, 2024 BENDER LEWIS H President and CEO A Stock Option (right to buy Common Stock) 464805 $0.00 464,805.0000 0 9999.99% 0.00%
March 6, 2024 GOLDBERG MARK A Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 0 9999.99% 0.00%
March 6, 2024 Wesolowski John M See Remarks A Stock Option (right to buy Common Stock) 25000 $0.00 25,000.0000 0 9999.99% 0.00%
March 6, 2024 Leahy Emer Director A Stock Option (right to buy Common Stock) 50000 $0.00 50,000.0000 0 9999.99% 0.00%
March 6, 2024 BENDER LEWIS H President and CEO A Stock Option (right to buy Common Stock) 33574 $0.00 33,574.0000 0 9999.99% 0.00%